DepoMed CEO Arthur Higgins' 2018 pay stays at $4.8M
DepoMed reports 2018 executive compensation
By ExecPay News
Published: April 8, 2019
DepoMed reported fiscal year 2018 executive compensation information on April 8, 2019.
In 2018, seven DepoMed executives received on average a compensation package of $1.9M, a 28% decrease compared to previous year.
Average pay of disclosed executives at DepoMed
Arthur J. Higgins, Chief Executive Officer, received $4.8M in total, which is about the same as previous year. 66% of Higgins' compensation, or $3.2M, was in stock awards. Higgins also received $755K in non-equity incentive plan, $800K in salary, as well as $69K in other compensation.
Stanley Bukofzer, Senior Vice President and Chief Scientific and Technical Officer, received a compensation package of $2.2M. 71% of the compensation package, or $1.6M, was in stock awards.
Phillip B. Donenberg, Chief Financial Officer, earned $2M in 2018.
August J. Moretti, Chief Financial Officer, received $1.2M in 2018, which decreases by 31% compared to 2017.
Matthew M. Gosling, General Counsel, earned $1.1M in 2018, a 55% decrease compared to previous year.
Santosh J. Vetticaden, Chief Medical Officer, received $1.1M in 2018, which increases by 58% compared to 2017.
Daniel A. Peisert, Chief Financial Officer, earned $955K in 2018.
Related executives
Arthur Higgins
DepoMed
Chief Executive Officer
Daniel Peisert
DepoMed
Chief Financial Officer
Phillip Donenberg
DepoMed
Chief Financial Officer
August Moretti
DepoMed
Chief Financial Officer
Stanley Bukofzer
DepoMed
Senior Vice President and Chief Scientific and Technical Officer
Matthew Gosling
DepoMed
General Counsel
Santosh Vetticaden
DepoMed
Chief Medical Officer
You may also like
Source: SEC filing on April 8, 2019.